Tachykinin neuropeptides, such as substance P, are localized to a population of sensory fibers that innervate the mammalian female reproductive tract. In the present study, we have characterized tachykinin NK 1 receptor (NK 1 R), NK 2 receptor (NK 2 R), and NK 3 receptor (NK 3 R) gene expression by semiquantitative RT-PCR in uteri from ovariectomized rats and studied their regulation in response to 17␤-estradiol (E 2 ), progesterone (P 4 ), or a combination of both. In addition, we analyzed the expression and regulation of the neutral endopeptidase 24.11 (NEP), the most important enzyme involved in tachykinin degradation in the rat uterus. In uteri from control (olive oiltreated) rats, RT-PCR assays revealed single bands corresponding to the expected product sizes encoding complementary DNA for NK 1 R (232 bp), NK 2 R (491 bp), NK 3 R (325 bp), and NEP (221 bp). The identity of the amplified fragments was confirmed by DNA sequence analysis. Compared with control rats, NK 1 R messenger RNA (mRNA) was increased by 2-fold in uteri from rats treated with E 2 , was decreased by 3.3-fold in rats treated with P 4 , and was decreased by 1.8-fold in rats treated with both E 2 and P 4 . Uterine NK 2 R mRNA levels were not altered by any steroid treatment. E 2 treatment decreased by 15-fold NK 3 R mRNA. P 4 was without effect if administered alone and did not influence the E 2 -induced decrease in NK 3 R mRNA. NEP mRNA levels were about 4-fold lower in E 2 -treated than in P 4 -treated rats. Functional studies were carried out in uteri from E 2 -or P 4 -treated ovariectomized rats to characterize the contractile response evoked by the selective tachykinin receptor agonists [Sar 9 Met (O 2 ) 11 ]substance P (NK 1 R selective), [Nle 10 ]NKA-(4 -10) (NK 2 R selective), and [MePhe 7 ]NKB (NK 3 R selective) in the presence of the NEP inhibitor phosphoramidon (1 M). A marked correlation was observed between the magnitude of the contractile response to each agonist and the level of expression determined by RT-PCR for each tachykinin receptor. The present findings show that tachykinin NK 1 R, NK 2 R, NK 3 R, and NEP are expressed in the rat uterus and that ovarian steroids differentially regulate their expression. (Endocrinology 140: 2526 -2532, 1999) T HE TACHYKININS substance P (SP), neurokinin A (NKA), and neurokinin B (NKB) are widely distributed within the mammalian peripheral and central nervous system (1, 2). Anatomical, neurochemical, and pharmacological evidence suggests that these peptides could play a role as mediators of nonadrenergic, noncholinergic excitatory neurotransmission (3, 4). Tachykinins interact with three distinct types of receptors termed NK 1 (NK 1 R), NK 2 (NK 2 R), and NK 3 (NK 3 R), which are preferentially activated by SP, NKA, and NKB, respectively (3, 5, 6). The three tachykinin receptors have recently been cloned in different mammalian species and belong to the family of G protein-coupling cell membrane receptors (2, 7-10). In the rat, NK 1 R, NK 2 R, and NK 3 R consist of 407, 390, and 452 amino acid residues, respectively (7, 8, 11, 12) . The molecular characterization of tachykinin receptors provides an appropriate tool to investigate the tissue localization and regulation of expression of these molecules.
1.8-fold in rats treated with both E 2 and P 4 . Uterine NK 2 R mRNA levels were not altered by any steroid treatment. E 2 treatment decreased by 15-fold NK 3 R mRNA. P 4 was without effect if administered alone and did not influence the E 2 -induced decrease in NK 3 R mRNA. NEP mRNA levels were about 4-fold lower in E 2 -treated than in P 4 -treated rats. Functional studies were carried out in uteri from E 2 -or P 4 -treated ovariectomized rats to characterize the contractile response evoked by the selective tachykinin receptor agonists [Sar 9 Met(O 2 ) 11 ]substance P (NK 1 R selective), [Nle 10 ]NKA-(4 -10) (NK 2 R selective), and [MePhe 7 ]NKB (NK 3 R selective) in the presence of the NEP inhibitor phosphoramidon (1 M). A marked correlation was observed between the magnitude of the contractile response to each agonist and the level of expression determined by RT-PCR for each tachykinin receptor. The present findings show that tachykinin NK 1 R, NK 2 R, NK 3 R, and NEP are expressed in the rat uterus and that ovarian steroids differentially regulate their expression. (Endocrinology 140: 2526 -2532, 1999) T HE TACHYKININS substance P (SP), neurokinin A (NKA), and neurokinin B (NKB) are widely distributed within the mammalian peripheral and central nervous system (1, 2) . Anatomical, neurochemical, and pharmacological evidence suggests that these peptides could play a role as mediators of nonadrenergic, noncholinergic excitatory neurotransmission (3, 4) . Tachykinins interact with three distinct types of receptors termed NK 1 (NK 1 R), NK 2 (NK 2 R), and NK 3 (NK 3 R), which are preferentially activated by SP, NKA, and NKB, respectively (3, 5, 6) . The three tachykinin receptors have recently been cloned in different mammalian species and belong to the family of G protein-coupling cell membrane receptors (2, (7) (8) (9) (10) . In the rat, NK 1 R, NK 2 R, and NK 3 R consist of 407, 390, and 452 amino acid residues, respectively (7, 8, 11, 12) . The molecular characterization of tachykinin receptors provides an appropriate tool to investigate the tissue localization and regulation of expression of these molecules.
SP and NKA have been localized to a population of nerve fibers, mostly of sensory origin, in the female reproductive tract of mammals (13) (14) (15) . To our knowledge, there is no evidence supporting the existence of NKB in these sensory nerves. In uteri from estrogen (E 2 )-treated, virgin rats SP, NKA, and NKB induce contractile responses that seem mainly mediated by activation of NK 2 R (16, 17) . Tachykinin NK 1 R and NK 2 R messenger RNAs (mRNAs) are expressed in appreciable amounts in E 2 -treated uteri, whereas NK 3 R mRNA is present in trace amounts, only detectable by amplification of large quantities of uterine complementary DNA (cDNA) (17) . However, radioligand binding studies demonstrated the presence of NK 3 R in uteri from rats in the diestrous stage of the estrous cycle (18) . Moreover, NK 3 R mRNA was found in uteri from ovariectomized rats, being present in a higher amount in animals treated with olive oil than in E 2 -treated animals (19) . Little information is available on the mechanisms responsible for regulating tachykinin receptor gene expression. Corticosteroids have been shown to reduce NK 1 receptor mRNA in rat pancreatic AR42J cells (20) and human lung (21) , suggesting the presence of a negative glucocorticoid-responsive element in this gene. In the present work, we studied the expression of tachykinin NK 1 R, NK 2 R, and NK 3 R in uteri from ovariectomized rats and whether ovarian steroids modulate this expression. We also analyzed the expression and hormonal regulation of the neutral endopeptidase 24.11 (NEP) or enkephalinase, which appears to be the most important enzyme involved in tachykinin degradation in the rat uterus (16, 17 7 ]NKB (NK 3 R selective) in E 2 -or P 4 -treated uteri and correlated the changes in tachykinin receptor mRNA expression with the changes in myometrial contractility after selective activation of NK 1 R, NK 2 R, or NK 3 R.
Materials and Methods

Animals and tissue preparation
Virgin female Wistar rats were purchased from Charles River (Criffa, Spain). All studies were conducted in accordance with the NIH Guide for the Use of Laboratory Animals, and the procedures were approved by Instituto de Investigaciones Químicas Isla de la Cartuja. Threemonth-old animals were bilaterally ovariectomized under ether anesthesia. Fourteen days later, they were injected ip with E 2 (17␤-estradiol benzoate; 50 g/kg⅐day for 2 days), progesterone (P 4 ; 1 mg/kg⅐day for 3 days), or both. Control rats were treated with vehicle (olive oil) for 3 days. Rats were killed by decapitation 24 h after the last injection. Uteri were removed, trimmed of surrounding connective tissue, and opened longitudinally. Half of each uterine horn was used in RT-PCR studies, and the other half was used in functional studies.
RNA isolation
Total RNA from approximately 20 mg uterine tissue was isolated according to the method of Chomczynski and Sacchi (22) . The RNA pellet was resuspended in 50 l ribonuclease-free water and quantified by spectrophotometric measurement at 260 nm. The RNA samples were then denatured and separated on 1% agarose gels containing 0.66 m formaldehyde. Ethidium bromide-stained 28S and 18S ribosomal RNA bands were visualized under UV illumination to ensure the integrity of each RNA preparation. To eliminate contaminating genomic DNA, total RNA samples were treated with fast protein liquid chromatography pure deoxyribonuclease I (DNase I; Pharmacia Biotech, Uppsala, Sweden). RNA samples (10 g each) were incubated at 37 C for 10 min with 10 U DNase I in DNase buffer [40 mm Tris-HCl (pH 7.5), 6 mm MgCl 2 , and 10 U ribonuclease inhibitor RNasin; Promega Corp., Madison, WI]. The reaction was stopped by extraction with phenol-chloroform (1:1, vol/vol), and RNA samples were ethanol precipitated, dried, resuspended in diethylpyrocarbonate-treated water, and stored at Ϫ70 C until use.
RT-PCR studies
First strand cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase and random hexamers according to Pharmacia's instructions (first strand cDNA synthesis kit, Pharmacia Biotech) in a 15-l volume reaction containing 5 g DNase-treated total RNA. PCR was used to detect the mRNA types for NK 1 R, NK 2 R, NK 3 R, or NEP using specific oligonucleotide primers for each one. Amplification of the ␤-actin gene transcript was used to control the efficiency of RT-PCR among the samples. Primers designed for tachykinin receptors and NEP, their sizes, and appropriate references are shown in Table 1 . Sequences of sense and antisense primers for ␤-actin were 5Ј-CCTAGCACCAT-GAAGATCAA-3Ј and 5Ј-TTTCTGCGCAAGTTAGGTTTT-3Ј, respectively (23, 24) . The expected size of the PCR product was 227 bp. PCR mixes contained 0.2 m primers, 1.5 U Taq polymerase (Pharmacia Biotech), the buffer supplied, 2.5 mm MgCl 2 , 200 m deoxy-NTPЈs, and cDNA in 25 L. Each experiment also contained two negative controls, one with the RT reaction containing no added RNA and the other one containing RNA that had not been reverse transcribed. PCR reactions were carried out using a thermocycle programmable heating block (Pharmacia Biotech). After heating at 94 C for 2 min, the parameters used for PCR amplification were as follows: denaturation, 30 s at 94 C; annealing, 30 s at 58 C; and extension, 30 s at 72 C. Cycle numbers were 35 for tachykinin receptors, 36 for NEP, and 24 for ␤-actin. PCR products were separated by gel electrophoresis on 1.7% agarose, stained with ethidium bromide, and visualized and photographed under a UV transilluminator (Photodyne, New Berlin, WI).
A semiquantitative RT-PCR assay was used to determine the relative concentrations of NK 1 R, NK 2 R, NK 3 R, and NEP mRNA in uteri from different treatment groups (25) . Equal aliquots of the RT solution (corresponding to 100 ng total RNA) for the samples to be compared were serially diluted in a 1:2 ratio and then amplified for a fixed number of cycles to ensure analysis of products in the exponential range of amplification. In this range, the amount of PCR product derived from a given amount of total RNA in a sample is directly proportional to the concentration of target mRNA in the sample (25, 26) . The observation of a steadily declining yield of product at each dilution step confirmed that the reaction had not entered the plateau phase and, therefore, that the comparison of the samples was made in the exponential portion of the amplification curve. mRNA levels for the three tachykinin receptors, NEP, and ␤-actin were analyzed on each uterine sample, with each RT-PCR assay performed at least in triplicate. Experiments were carried out in five different animals per each condition, i.e. treatment with olive oil, E 2 , P 4 , or E 2 plus P 4 . Tachykinin receptor and NEP mRNA expression levels were normalized to ␤-actin mRNA levels, and the relative amount of the target sequence in E 2 -, P 4 -or E 2 plus P 4 -treated rats was expressed as a percentage of the value determined in olive oil-treated animals. DNA fluorescence in ethidium bromide-stained gels was densitometrically scanned using a video documentation system and the image analysis software intelligent quantifier (BioImage Systems Corp., Ann Arbor, MI).
In some experiments, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used instead of ␤-actin as the internal standard. The sense and antisense primers employed were 5Ј-ACCACAGTCCATGCCAT-CAC-3Ј and 5Ј-TCCACCACCCTGTTGCTGTA-3Ј. The number of cycles for PCR amplification was 30, and the size of the PCR product was 452 bp. After normalization to GAPDH mRNA levels, semiquantitative RT-PCR studies were carried out as described above.
DNA sequence analysis
Nucleotide sequences were determined using the fmol sequencing system (Promega Corp.), as previously described (27) .
Functional studies
Longitudinal strips of uterine smooth muscle (8 -10 mm in length and 1-2 mm in diameter) were prepared and mounted in siliconized (with 5% dimethyl-dichlorosilane in chloroform; Sigma Chemical Co., St. Louis, MO) tissue baths containing 4 mL physiological salt solution of the following composition: 154 mm NaCl, 5.6 mm KCl, 1.9 mm CaCl 2 , 0.95 mm MgCl 2 , 5.95 mm NaHCO 3 , and 2.78 mm glucose, gassed with 95% O 2 -5% CO 2 . The bathing solution was maintained at 37 C. Mechanical responses were recorded isometrically by means of force displacement transducers (FT-03, Grass Instruments, Quincey, MA) connected to an amplifier (LETICA, Barcelona, Spain) and a recorder (SE 130, ABB Goerz, Zurich, Switzerland). The preparations, stretched to the optimal resting force of 5 millinewtons, were equilibrated for 45 min, during which time 
Shown are the structures of forward (F) and reverse (R) primers of the indicated receptor types. The table shows the size of the PCRamplified product of each receptor and NEP mRNA and the references from which these primers were designed. they were washed with fresh solution every 15 min. After equilibration, the preparation was induced to contract two or more times by the administration of a maximally effective concentration of acetylcholine (ACh; 1 mm) at 30- 7 ]NKB was constructed on each uterine strip. Each agonist concentration remained in contact with the tissue for 5 min, and the tissue was then washed thoroughly and allowed to rest for 20 min before the addition of the next concentration. Responses to all tachykinins tested were obtained in the presence of the neutral endopeptidase inhibitor phosphoramidon (N-(␣-l-rhamnopyranosyl-oxyhydroxyphosphinyl)-l-leucyl-l-tryptophan sodium salt, Sigma Chemical Co.). A maximally effective concentration of phosphoramidon (1 m) (17) was added to the bath 20 min before the tachykinin analog and reapplied after wash-out of each agonist concentration. At the end of the experiment, the preparation was washed repeatedly for 60 min before application of ACh (1 mm 7 ]NKB) during the 5-min period that each concentration of an agent was in contact with the preparation. The responses were expressed as a percentage of the peak increase in force or in the area under the force-time curve measured during a 5-min period for ACh (1 mm). To measure the areas, polygraph tracings were scanned and then processed using the Sigma-Scan software package (Jandel Scientific Corp., Erkrath, Germany).
Statistical analysis
All values are presented as the mean Ϯ sem; n represents the number of different animals. Statistical significance of differences between two means was assessed using Student's paired or unpaired t test. Multiple means were compared by one-way ANOVA using the Bonferroni multiple comparison test (Instat, version 2.02, GraphPad Software, Inc., San Diego, CA). In functional studies, P Ͻ 0.05 was considered significant. In RT-PCR studies, P Ͻ 0.001 was regarded as significant.
Results
RT-PCR studies
RT-PCR analysis of uterine mRNA from olive oil-treated ovariectomized rats revealed the presence of single transcripts corresponding to the sizes expected for NK 1 R (232 bp), NK 2 R (491 bp), NK 3 R (325 bp), and ␤-actin (227 bp; Fig.  1 ). The identity of PCR products was confirmed by determination of DNA nucleotide sequences. This analysis demonstrated that the sequence of the amplified PCR fragments was identical to those previously reported for the rat brain NK 1 R (nucleotide positions 804-1035 bp, according to Refs. 11 and 12), the rat stomach NK 2 R (nucleotide positions 513-1003 bp, according to Ref. 7) , and the rat brain NK 3 R (nucleotide positions 918-1242 bp, according to Ref. 8) . Similarly, the rat ␤-actin-amplified sequence was identical to that previously published (23) . In all experiments, the two negative controls yielded no detectable products, indicating that 1) all reagents were free of target sequence contamination; and 2) the RT-PCR products do not come from contaminating genomic DNA.
To determine whether tachykinin receptor gene expression was regulated by ovarian steroids, we performed semiquantitative RT-PCR analysis of RNA extracted from uteri of ovariectomized rats after in vivo treatment with E 2 or P 4 ( Fig.  1) . Additional experiments were performed in uteri from animals treated with both E 2 and P 4 . Compared with control (olive oil-treated) rats, E 2 treatment caused a 1.9-fold increase in NK 1 R mRNA levels. P 4 led to a 3.3-fold decrease when administered alone and suppressed the E 2 -induced NK 1 R mRNA rise in rats treated with both E 2 and P 4 ( Fig. 2A) . Neither E 2 nor P 4 produced significant alterations in tachykinin NK 2 R mRNA expression (P Ͼ 0.001; Fig. 2B ). E 2 treat-FIG. 1. Agarose gels showing RT-PCR products for uterine cDNA from P 4 -treated (lanes 1-6), estrogen-treated (E 2 ; lanes 7-12), and olive oil-treated [control (C); lanes 13-18] ovariectomized rats. After normalization to ␤-actin mRNA levels, equal aliquots of the RT solution were serially diluted in a 1:2 ratio and amplified for 24 (␤-actin) or 35 (tachykinin receptors) cycles with ␤-actin-and tachykinin receptor-specific primers. Lanes 6, 12, and 18 represent the more diluted samples in each series. The observation of a steadily declining yield of product at each dilution step confirmed that the comparison of the two samples was made in the exponential portion of the amplification curve. The amounts of NK 1 R, NK 2 R, and NK 3 R mRNA were then assessed relative to the amount of the coamplified ␤-actin fragment. m, Molecular size standards. Data are representative of typical results in 15 different animals. ment led to a 14.3-fold decrease in uterine NK 3 R mRNA levels (Fig. 2C ). P 4 was without effect, if administered alone, and did not influence the E 2 -induced decrease in NK 3 R mRNA (Fig. 2C) .
Amplification of uterine cDNA from control ovariectomized rats with specific NEP primers generated a single band of the expected size (221 bp). The sequence of the amplified fragment was identical to that previously reported for the rat NEP (28) . Compared with controls, NEP mRNA expression was decreased 2-fold in rats treated with E 2 and was increased 1.9-fold in rats treated with P 4 (Fig. 3) . Compared with controls, the decrease observed in rats treated with both E 2 and P 4 (1.5-fold) did not reach statistical significance (P Ͼ 0.001; Fig. 3 ). NEP mRNA expression levels in E 2 -plus P 4 -treated rats were not significantly different from those in E 2 -treated rats (P Ͼ 0.001; Fig. 3 ), but were significantly lower than mRNA levels in P 4 -treated rats (P Ͻ 0.001; Fig. 3) . Changes in the relative mRNA levels of tachykinin receptors and NEP in animals treated with E 2 , P 4 , or E 2 plus P 4 were similar, compared with those in control animals, when GAPDH was used instead of ␤-actin as the internal standard (n ϭ 2 animals/treatment group; data not shown). -1 m) induced concentration-dependent contractile responses that were virtually identical in uteri from E 2 -or P 4 -treated rats (Fig. 4B) . Among the tachykinin agonists tested, [Nle 10 ]NKA-(4 -10) showed the higher E max ; the maximal contraction was similar in amplitude to that produced by a maximally effective concentration of ACh (1 mm). The NK 3 R-selective agonist [MePhe 7 ]NKB (1 nm-1 m) elic-
Functional studies
Effect of E 2 , P 4 , or E 2 plus P 4 on NK 1 R, NK 2 R, and NK 3 R mRNA levels in uteri from ovariectomized rats. The relative mRNA level for each tachykinin receptor in each tissue was determined as the ratio of NK 1 R, NK 2 R, or NK 3 R mRNA/␤-actin mRNA measured by densitometry. After normalization to ␤-actin, expression of each tachykinin receptor mRNA in uteri from control (olive oil-treated) rats (C) was considered as 1. Each bar represents the mean Ϯ SEM in five animals. †, P Ͻ 0.001 (significant difference from mRNA levels in control rats); ␦, P Ͻ 0.001 (significant difference from mRNA levels in E 2 -treated rats); §, P Ͻ 0.001 (significant difference from mRNA levels in P 4 -treated rats; all by one-way ANOVA). FIG. 3 . Effect of E 2 , P 4 , or E 2 plus P 4 on NEP mRNA levels in uteri from ovariectomized rats. The relative NEP mRNA level in each tissue was determined as the ratio of NEP mRNA/␤-actin mRNA measured by densitometry. After normalization to ␤-actin, expression of NEP mRNA in uteri from control (olive oil-treated) rats (C) was considered as 1. Each bar represents the mean Ϯ SEM in five different animals. †, P Ͻ 0.001 (significant difference from mRNA levels in control rats); §, P Ͻ 0.001 (significant difference from mRNA levels in P 4 -treated rats; both by one-way ANOVA).
ited contractions that were less than 10% of the maximum response to ACh (1 mm) in uteri from E 2 -treated rats (Fig. 4C) . [MePhe 7 ]NKB induced greater uterine contraction in P 4 -treated animals; the maximal effect was reached at 10 nm (Fig. 4C ). Higher concentrations (30 nm to 1 m) elicited contractile responses of decreasing amplitude, probably reflecting receptor desensitization, a phenomenon that has been previously described for NK 3 R in other tissues (29) .
Discussion
The present results demonstrate that NK 1 R, NK 2 R, and NK 3 R and NEP are expressed in uteri from ovariectomized rats, and that mRNA expression levels for the three tachykinin receptor types and NEP are selectively and differentially regulated by ovarian steroids. This study also shows that changes in the amount of tachykinin receptor mRNAs correlate with changes in functional responses to agonists acting selectively at NK 1 R, NK 2 R, or NK 3 R.
Three types of tachykinin receptors have been characterized by pharmacological, biochemical, and molecular studies (2, 6) . NK 1 R is the receptor with highest affinity for SP; NK 2 R is the receptor with highest affinity for NKA, and NK 3 R is the receptor with highest affinity for NKB-(4 -6). In the female reproductive tract, SP and NKA have been shown to be present in virtually all mammalian species examined (13) (14) (15) . These neuropeptides could influence myometrial activity as well as other reproductive functions in females (15, 30) . However, little is known about the tachykinin receptor types expressed in the uterus, their regulation, and their role in uterine function.
Immunocytochemical studies have shown that numerous SP-positive neurons innervate the myometrium and uterine arteries in mammals, suggesting that the female genital tract is an important target organ for SP (13) (14) (15) 31) . This neuropeptide increases uterine blood flow, relaxes vascular smooth muscle, and increases the mechanical and myoelectrical activities of uterine smooth muscle (15, 17, 31) . In the rat, SP can modulate the IgE-mediated release of histamine and inflammatory cytokines from uterine mast cells in different ways, depending on the phase of the reproductive cycle (30) . SP is the preferred endogenous ligand for tachykinin NK 1 R, but it is not selective enough and can also activate tachykinin NK 2 R and NK 3 R types (6). To our knowledge, the physiological relevance of NK 1 R in the female reproductive tract has not yet been established. The observation that mRNA encoding tachykinin NK 1 R is expressed in the rat uterus suggests that NK 1 R could play a role in mediating uterine responses to tachykinins. Our data indicate that NK 1 R gene expression was decreased after treatment of ovariectomized rats with P 4 . These results are consistent with those previously reported by Gorbulev et al. (32) , who found that NK 1 R mRNA levels are reduced during pregnancy in the guinea pig uterus. It has also been reported that P 4 selectively and negatively regulates the expression of the NK 1 R gene in rat pancreatic acinar cells (20) . The effect of E 2 appears less clear. In rat pancreatic acinar AR42J cells, E 2 increased NK 1 R gene expression (33) or had no effect (20) . In our study, E 2 raised NK 1 R mRNA levels by 1.9-fold when administered alone. NK 1 R-encoding mRNA was decreased by 3.3-fold in rats treated with P 4 and by 1.8-fold in rats treated with both E 2 and P 4 . The contractile response evoked by the selective NK 1 R agonist [Sar 9 Met(O 2 ) 11 ]SP was significantly higher in E 2 -treated than in P 4 -treated animals. Taken together, these results suggest that E 2 up-regulates NK 1 R expression in the rat uterus. Values are means for five experiments in five animals; vertical lines show the SEM. *, P Ͻ 0.05; **, P Ͻ 0.01; †, P Ͻ 0.001 (significant differences from uterine responses in E 2 -treated rats, by unpaired t test).
Contractile responses to SP, NKA, and NKB in uteri from noncastrated, virgin rats treated with E 2 are mainly mediated by activation of NK 2 R (16, 17) . Radioligand binding studies have also demonstrated the presence of tachykinin NK 2 R in uteri from either E 2 -treated or untreated rats (16, 18) . Our data extend these observations and show that tachykinin NK 2 R mRNA is expressed in uteri from ovariectomized rats.
The present results also demonstrate that treatment of rats with E 2 or P 4 had no effect on the uterine level of NK 2 R mRNA. Adcock et al. (21) showed that NK 2 R mRNA expression in human lung was unaffected by dexamethasone. These data suggest that the expression of this tachykinin receptor type is not subject to modulation by steroid hormones.
Virtually nothing is known about the role that NKB and NK 3 R may play in the female reproductive system. To our knowledge, the presence of NKB in the genital tract has not been demonstrated. The NK 3 R is widely distributed in the central nervous system and is present in smaller amounts in peripheral tissues (1, 8) . NK 3 R mRNA is undetectable or present in trace amounts in E 2 -treated uteri from noncastrated, virgin rats (17) . Barr et al. (18) carried out radioligand binding studies with [
125 I]Bolton-Hunter eledoisin and found NK 3 R in uteri from rats in the diestrous stage of the estrous cycle. The present data demonstrate that the NK 3 R gene is expressed in uteri from olive oil-treated ovariectomized rats. A novel human NK 3 R homolog has recently been characterized (34, 35) . This novel NK 3 R exhibits a great protein sequence similarity to that of the rat NK 3 R, with an overall identity of approximately 80%. The NK 3 R fragment amplified in this study encoded the third extracellular loop, the transmembrane segment VII, and a portion of the cytoplasmic carboxyl-terminal. Within this region, there are 57 different nucleotides between the rat NK 3 R and the recently described human NK 3 R homolog. The observation that the deduced nucleotide sequence was identical to that previously reported for the rat brain NK 3 receptor confirms that the fragment corresponds to the classical NK 3 receptor cloned by Shigemoto et al. (8) . Our study shows that the NK 3 R mRNA level was not affected by P 4 , but was strongly down-regulated in response to E 2 administration. This suggests that E 2 has a marked negative regulatory effect on the expression of NK 3 R in the rat uterus.
Enkephalinase or NEP 24.11 appears to be the most important enzyme involved in tachykinin metabolism in the rat uterus (16, 17) . In addition to changes in tachykinin receptor mRNA levels, changes in NEP gene expression may be of physiological importance in modulating tachykinin-induced uterine responses. In our study, NEP mRNA levels were 4-fold higher in P 4 -treated than in E 2 -treated animals, suggesting that NEP gene expression in the rat uterus is under hormonal control. If we accept that changes in gene expression correlate with changes in the amount of protein, the increased expression of NEP in uteri under P 4 dominance would lead to a higher degradation of tachykinins, thus reducing uterine responsiveness to these neuropeptides. A slower degradation of tachykinins must be expected in E 2 -dominated uteri.
Steady-state mRNA levels may not correlate with the amount of functional protein produced. The translation efficiency, its processing and turnover, and its transport and translocation to the membrane have to be considered. Therefore, it remains to be determined whether alterations in mRNA expression levels seen in this study result in an altered number of functional tachykinin receptors expressed on the plasma membrane. As mentioned previously, autoradiography and radioligand binding studies have demonstrated the presence of tachykinin NK 1 R, NK 1 R, and NK 3 R in the rat uterus (16, 18) . It has also been reported that functional responses evoked by SP or the NK 1 R agonist SP methyl ester in uterine tissues varied markedly depending on the stage of the estrous cycle (18, 30) . We studied the contractions evoked by selective NK 1 , NK 2 , and NK 3 receptor agonists in uterine strips from the same ovariectomized animals in which mRNA expression levels were determined and observed a marked correlation between variations in myometrial contractility and mRNA abundance for each tachykinin receptor. These data support the hypothesis that changes in steady state receptor mRNA levels are probably accompanied by alterations in the sensitivity of uterine cells to tachykinins. Further studies with the recently characterized antisera specific to NK 1 R, NK 2 R, and NK 3 R (36) would help to clarify this issue.
In the uterus, E 2 stimulates the growth of the uterus, causing hyperemia, increased vascular permeability, and edema (37). E 2 and P 4 regulate the influx of eosinophils and macrophages into the uterus (37) . Tachykinins, particularly SP, are thought to act as neurogenic inflammatory factors in local inflammatory responses (38, 39) . They produce activation of inflammatory cells, vasodilatation, and increased vascular permeability leading to plasma extravasation and edema formation (38 -40) . The present data show that tachykinin NK 1 R, NK 2 R, and NK 3 R are expressed in the rat uterus. This and the observation that tachykinin receptor and neutral endopeptidase gene expression are selectively and differentially regulated by ovarian steroids suggest that tachykinins may participate in some way in the cascade of events occurring in the female genital tract during the estrous cycle and/or pregnancy.
